Cree (CREE) is a Zacks Rank #1 (Strong Buy) and sports the divergence that I love to see in the Zacks Style Scores. I see an A for Growth and a D for value and that tells me right away that I am on the right path. My focus is on aggressive growth, and I know that growth investors are looking for the opposite of what value investors are looking for. When I see that divergence, I know I found what I am looking for.
Today, CREE is the Bull of the Day. Let's take a look at why I like this stock right here.
First off, I see that it is in the chip space and while I normally say that chips are for dips -- right now they look like a tasty treat. The chip names are likely to move significantly higher when a China deal is announced due to the relationship that so many names have with that region and country specifically.
Secondly, a big buyer just put some cards on the table. Artisian Partners filed a 13G with the SEC stating that they control 8.1M shares. That was just announced the other day... and it follows an early January filing that saw Vanguard announced a 10.4M share position.
When I see big buyers of size on a stock with a great Zacks Rank, I know it is worth a much deeper look.
When a stock is a Zacks Rank #1 (Strong Buy) then we know the estimates are moving higher. That is the key part of the Zacks Rank.
I see the current quarter move higher by 2 cents, and the full year (fiscal 2019) has moved from $0.73 to $0.78.
The Zacks Consensus Estimate for fiscal 2020 has remained at $1.27 over the last 90 days.
The forward PE of 66x is a little rich, but when you look at the other metrics it doesn't look that bad. A see a 2.4x price to book multiple, which is pretty pretty good for a stock with a 12% topline growth rate. I also see a 3.4x price to sales multiple which is a little high but still within an acceptable range.
Cree, Inc. Price and Consensus
Cree, Inc. Price and Consensus | Cree, Inc. Quote
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Zacks Investment Research